Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Adenosine and neuropathic pain

R Guieu1, J C Peragut, P Roussel

  • 1Laboratoire de Biochimie, URA CNRS 1455, Faculté de Médecine Secteur Nord, Marseille, France.

Pain
|December 1, 1996
PubMed
Summary

Neuropathic pain patients exhibit reduced adenosine levels in blood and cerebrospinal fluid (CSF). This deficiency may explain why adenosine treatments show therapeutic potential for neuropathic pain relief.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Natural healing factors of Nalchik resort in medical rehabilitation of the patients with post-traumatic stress disorder. (Randomized controlled trial)].

Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury·2024
Same author

Correction to "Unveiling the Electronic Structure of Pseudotetragonal WO<sub>3</sub> Thin Films".

The journal of physical chemistry letters·2023
Same author

Unveiling the Electronic Structure of Pseudotetragonal WO<sub>3</sub> Thin Films.

The journal of physical chemistry letters·2023
Same author

Optimal solution of the fractional order breast cancer competition model.

Scientific reports·2021
Same author

Observation of chemically protected polydimethylsiloxane: towards crack-free PDMS.

Soft matter·2017
Same author

Environmental hydro-refugia demonstrated by vegetation vigour in the Okavango Delta, Botswana.

Scientific reports·2016

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pain Management

Background:

  • Neuropathic pain is a debilitating condition often inadequately managed by current therapies.
  • Adenosine and its analogs have shown promise in preclinical studies for neuropathic pain relief.
  • A potential metabolic anomaly in adenosine pathways could underlie neuropathic pain pathophysiology.

Purpose of the Study:

  • To investigate whether metabolic anomalies of adenosine are present in patients with neuropathic pain.
  • To compare circulating adenosine levels in neuropathic pain patients versus control groups.

Main Methods:

  • Adenosine levels were measured in the blood of four patient groups: neuropathic pain, nervous system lesions without pain, pain from excessive nociception, and controls.
  • Cerebrospinal fluid (CSF) adenosine levels were also assayed in a subset of patients.

Related Experiment Videos

Main Results:

  • Patients with neuropathic pain showed significantly reduced levels of adenosine in both blood and CSF.
  • No significant differences in adenosine levels were observed in patients with nervous system lesions without pain or those with pain from excessive nociception compared to controls.

Conclusions:

  • Reduced circulating and CSF adenosine levels represent a potential metabolic anomaly in neuropathic pain.
  • This adenosine deficiency may underlie the pathophysiology of neuropathic pain and explain the efficacy of adenosine-based therapies.